Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials

INTRODUCTION: The adjuvanted recombinant zoster vaccine (RZV) has demonstrated high efficacy against herpes zoster in older adults and immunocompromised populations. We present comprehensive safety data from six clinical trials in immunocompromised populations (autologous hematopoietic stem cell tra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Saf
Main Authors: López-Fauqued, Marta, Co-van der Mee, Maribel, Bastidas, Adriana, Beukelaers, Pierre, Dagnew, Alemnew F., Fernandez Garcia, Juan Jose, Schuind, Anne, Tavares-da-Silva, Fernanda
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2021
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217041/
https://ncbi.nlm.nih.gov/pubmed/34115324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-021-01076-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados